speb/financial-data huggingface dataset:
MSCL.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 13827830.54
MSCL.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -13206693.80
MSCL.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -13568.52
MSCL.TO balance_sheet (annual, 2023-12-31) — Receivables: 441000.00
MSCL.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 5276.65
MSCL.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1976481.23
MSCL.TO income_statement (annual, 2023-12-31) — Research And Development: 6646313.89
MSCL.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -36463000.00
MSCL.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 2729534.15
MSCL.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
MSCL.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 4567314.94
MSCL.TO balance_sheet (annual, 2023-12-31) — Share Issued: 9399304.00
MSCL.TO income_statement (annual, 2023-12-31) — Special Income Charges: -321121.66
MSCL.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1635006.78
MSCL.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 30756000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 30756000.00
MSCL.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MSCL.TO income_statement (annual, 2023-12-31) — Tax Provision: 0.00
MSCL.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 441000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Assets: 33490000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 30756000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 30756000.00
MSCL.TO income_statement (annual, 2023-12-31) — Total Expenses: 11656113.37
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2734000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 3007000.00
MSCL.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MSCL.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -11656113.37
MSCL.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -1192522.24
MSCL.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1192522.24
MSCL.TO balance_sheet (annual, 2023-12-31) — Working Capital: 27749000.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 9418933.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.72
MSCL.TO cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -440.89
MSCL.TO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 9418933.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.72
MSCL.TO cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
MSCL.TO balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
MSCL.TO balance_sheet (quarterly, 2024-09-30) — Gross PPE: 12582.53
MSCL.TO income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 2905000.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Interest Expense: 0.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 0.00
MSCL.TO balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: -39000.00
MSCL.TO balance_sheet (quarterly, 2024-09-30) — Other Properties: 12582.53
MSCL.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: -2905000.00
MSCL.TO income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: -3700000.00
MSCL.TO income_statement (annual, 2024-12-31) — +Operating Expense: 20398000.00
MSCL.TO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 2063000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 7900000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 2905000.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -171815.37
MSCL.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 9564861.00
MSCL.TO income_statement (annual, 2024-12-31) — Basic EPS: -2.16
MSCL.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 16681000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -4000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 78131000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 40073000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 48548000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 15688000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 24385000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 37574000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 4656000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -18252000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1012000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1733000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -32000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -753000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 23978000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Common Stock: 78131000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 47164000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 30057000.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 29823228.98
MSCL.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1520000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Current Assets: 50743000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 3583000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Depreciation: 15000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 15000.00
MSCL.TO income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 15000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 15000.00
MSCL.TO income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 15000.00
MSCL.TO income_statement (annual, 2024-12-31) — Depreciation Income Statement: 15000.00
MSCL.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 9564861.00
MSCL.TO income_statement (annual, 2024-12-31) — Diluted EPS: -2.16
MSCL.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — EBIT: -20398000.00
MSCL.TO income_statement (annual, 2024-12-31) — EBITDA: -20383000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -586000.00
MSCL.TO cash_flow (annual, 2024-12-31) — End Cash Position: 40073000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 37574000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -18256000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 3000.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -826.90
MSCL.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1666000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1737000.00
MSCL.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 5452000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
MSCL.TO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 0.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 3483.86
MSCL.TO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 3483.86
MSCL.TO balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 0.00
MSCL.TO balance_sheet (quarterly, 2024-12-31) — Hedging Assets Current: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 2905000.00
MSCL.TO income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: -171815.37
MSCL.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Interest Expense: 0.00
MSCL.TO income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
MSCL.TO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Interest Income: 1003000.00
MSCL.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1003000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 47164000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 4656000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
MSCL.TO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
MSCL.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 30057000.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 29823228.98
MSCL.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
MSCL.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
MSCL.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 30057000.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 29823228.98
MSCL.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -1071000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -20634000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -20634000.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Interest Income: 1003000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 4660000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1003000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Net PPE: 4000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 47164000.00
MSCL.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -19144000.00
MSCL.TO income_statement (annual, 2024-12-31) — Normalized Income: -19395000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -18252000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -1068000.00
MSCL.TO income_statement (annual, 2024-12-31) — Operating Income: -20398000.00
MSCL.TO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 13818322.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1737000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Other Equity Interest: 19967000.00
MSCL.TO income_statement (annual, 2024-12-31) — Other Gand A: 1688000.00
MSCL.TO income_statement (annual, 2024-12-31) — Other Income Expense: -1239000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -358000.00
MSCL.TO income_statement (annual, 2024-12-31) — Other Operating Expenses: 572000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Other Properties: 3483.86
MSCL.TO balance_sheet (quarterly, 2024-12-31) — Other Properties: 3483.86
MSCL.TO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 8475000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Payables: 2063000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 3583000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1760000.00
MSCL.TO income_statement (annual, 2024-12-31) — Pretax Income: -20634000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 7517000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -27416000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Receivables: 435000.00
MSCL.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 15000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
MSCL.TO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Research And Development: 14359000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -57097000.00
MSCL.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 3764000.00
MSCL.TO cash_flow (annual, 2024-12-31) — Sale Of Investment: 32076000.00
MSCL.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 5452000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Share Issued: 13818322.00
MSCL.TO income_statement (annual, 2024-12-31) — Special Income Charges: -2905000.00
MSCL.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 171815.37
MSCL.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1641000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 47164000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 47164000.00
MSCL.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Tax Provision: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 435000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Assets: 50747000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 47164000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 47164000.00
MSCL.TO income_statement (annual, 2024-12-31) — Total Expenses: 20398000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3583000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 4000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -19375831.77
MSCL.TO income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -4576560.08
MSCL.TO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
MSCL.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -1239000.00
MSCL.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1239000.00
MSCL.TO balance_sheet (annual, 2024-12-31) — Working Capital: 47160000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 6479000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1885000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 8347000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 13818707.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.44
MSCL.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 40073000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 78134000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 32712000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 41190000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 25598000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Cash Financial: 7114000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -7366000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -886000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -1077000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 98000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1865000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -7364000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 78134000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 41669000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 751000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 44365000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2699000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 1000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 1000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 1000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 13818707.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.44
MSCL.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — EBIT: -6479000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — EBITDA: -6478000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 3000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 32712000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -7366000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 8000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1541000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1792000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 63000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Interest Income: 393000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 393000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 41669000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 0.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -3000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -6141000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -6141000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 393000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 393000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 3000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 41669000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -6486000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -6147800.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -7366000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -3000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Operating Income: -6479000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 13818739.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1541000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 19967000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 529000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 8000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 144000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 3000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8478000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Payables: 1948000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2699000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 2837000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Pretax Income: -6078000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 2000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 338000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Research And Development: 4542000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -63238000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1263000.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1792000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 13818739.00
MSCL.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 642000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 41669000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 41669000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1200.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 63000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 338000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 44368000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 41669000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 41669000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 6479000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2699000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 63000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 8000.00
MSCL.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 8000.00
MSCL.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 41666000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 6367000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1060000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 8775000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 14268902.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.36
MSCL.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 32712000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 82512000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 38217000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 38217000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 28002000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 10215000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1392000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 8472000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -4843000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 40000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 128000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 151000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 319000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 5021000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 82512000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 38347000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1615000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 41112000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2770000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 0.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 0.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 1000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 0.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 1000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 14268902.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.36
MSCL.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — EBIT: -6367000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — EBITDA: -6366000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 484000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 38217000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1392000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -4846000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 429000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1675000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1744000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 0.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Hedging Assets Current: 0.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 95000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Interest Income: 362000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 362000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 38347000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 8472000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 0.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -388000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5608000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5608000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 362000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 8475000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 362000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 38347000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6795000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Normalized Income: -5972650.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4843000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -388000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Operating Income: -6367000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 14692113.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1675000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 17581000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 427000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: 429000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 187000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 0.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Payables: 1155000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2770000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2709000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Pretax Income: -5576000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1392000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 186000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 0.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Research And Development: 4435000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -68846000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1317000.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 8475000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1744000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 14692113.00
MSCL.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 834000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 38347000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 38347000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 64350.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 32000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 186000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 41117000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 38347000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 38347000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 6367000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2770000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 5000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -6367000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 95000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 429000.00
MSCL.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 429000.00
MSCL.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 38342000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 5966000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1385000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 9316000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 13944932.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.36
MSCL.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 38217000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -3000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 85546000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 19304000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 34614000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 13072000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6232000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 700000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -15332000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4126000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 790000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 31000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -18000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 803000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -18758000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 85546000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 34000000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2004000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 37497000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3503000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Depreciation: 3000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 2000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 13944932.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.36
MSCL.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — EBIT: -5966000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — EBITDA: -5963000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -155000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 19304000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 700000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4129000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -185000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1675000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1864000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 0.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 114000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Interest Income: 349000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 349000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 34000000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -15332000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: 115000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -5821000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -5821000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 349000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -15329000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 349000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 6000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 34000000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -5778000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Normalized Income: -5663750.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4126000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 115000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Operating Income: -5966000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 15424465.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1675000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 15480000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 686000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -185000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 106000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 15310000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Payables: 1499000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3503000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2678000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Pretax Income: -5802000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 700000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -15329000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 205000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Research And Development: 3994000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -74667000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1178000.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1864000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 15424465.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MSCL.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 774000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 34000000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 34000000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -27750.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 19000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 205000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 37503000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 34000000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 34000000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 5966000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3503000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -5966000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 114000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -185000.00
MSCL.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -185000.00
MSCL.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 33994000.00
MSCL.TO income_statement (annual, 2025-12-31) — +Operating Expense: 26459000.00
MSCL.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 7647000.00
MSCL.TO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
MSCL.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 1772000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1772000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 10166000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 10166000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MSCL.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 14595771.00
MSCL.TO income_statement (annual, 2025-12-31) — Basic EPS: -1.70
MSCL.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 40073000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 19304000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -6000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 85828000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 85828000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 9804000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 9804000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27710000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27710000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 5420000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 5420000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 4384000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 4384000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2241000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 147000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -9417000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2557000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -23596000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -7261000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 501000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 557000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -2044000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1126000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 65000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -166000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -1478000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -735000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -30772000.00
MSCL.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -9671000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Common Stock: 85828000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 85828000.00
MSCL.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 27784000.00
MSCL.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 27784000.00
MSCL.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00